Immunohistological analysis of tumour growth factor β1 expression in normal and inflamed salivary glands

Journal of Clinical Pathology

Volumn 49, Issue 9, 1996, Pages 728-732

  Kizu, Y ^a   Sakurai, H ^c   Katagiri, S ^a   Shinozaki, N ^b   Ono, M ^b   Tsubota, K ^b   Saito, I ^c,d  

^a TOKYO DENTAL COLLEGE   (Japan)

^b Department of Ophthalmology ^*

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Salivary gland; Sjogren's syndrome; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SIALOADENITIS; SJOEGREN SYNDROME;

EID: 0029847976     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.9.728     Document Type: Article

References (30)

1. Sporn MB, Roberts AB. TGF-β: problems and prospects. Cell Regul 1990;1:875-82.
2. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990;63:245-7.
3. Keller JR, Mcniece IK, Sill KT, Ellingsworth LR, Quesenberry PJ, Sing GK, et al. Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation. Blood 1990;75:596-602.
4. Roberts AB, Sporn MB. Peptide growth factors and their receptors. In: The handbook of experimental pharmacology. Berlin: Springer Verlag, 1989:419.
5. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-5.
6. Brandtzaeg P. Overview of the mucosal immune system. Curr Top Microbiol Immunol 1989;146:13-25.
7. Lindahl G, Hedfors E, Klareskog L, Forsum U. Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol 1985; 61:475-82.
8. Fox RI, Bumol T, Fantozzi R, Bone R, Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum 1986;29:1105-11.
9. Adamson T, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983; 130:203-8.
10. Skopouli FN, Fox PC, Galanopoulou V, Atkinson JC, Jaffe ES, Moutsopoulos HM. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. J Rheumatol 1991;18:210-4.
11. Talal N, Bunim JJ. The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964;36:529.
12. Mann DL, Moutsopoulos HM. HLA DR alloantigens in different subsets of patients with Sjögren's syndrome and in family members. Ann Rheum Dis 1983;42:533-6.
13. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 1989;169:2191-8.
14. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9.
15. Fox RI, Saito I. Criteria for diagnosis of Sjögren's syndrome. Rheum Dis Clin North Am 1994;20:391-407.
16. Tsubota K. The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol 1991;111:106-8.
17. Flanders KC, Thompson NL, Cissel DS, Van OSE, Baker CC, Kass ME, et al. Transforming growth factor-β 1: histochemical localization with antibodies to different epitopes. J Cell Biol 1989;108:653-60.
18. Ristow HJ. BSC-1 growth inhibitor type beta transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci U S A 1986;83:5531-3.
19. Wahl SM, Hunt DA, Wong HL, Dougherty S, McCartney FN, Wahl LM, et al. Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 1988; 140:3026-32.
20. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez MM, Derynck R, et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163:1037-50.
21. Ortaldo JR, Mason AT, O'Shea JJ, Smyth MJ, Falk LA, Kennedy IC, et al. Mechanistic studies of transforming growth factor-β inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R β (p75) signal transduction. J Immunol 1991; 146:3791-8.
22. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol 1994;152:5532-9.
23. Tateishi M, Saito I, Yamamoto K, Miyasaka N. Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis. Arthritis Rheum 1993;36:827-35.
24. Saito I, Terauchi K, Shimuta M, Nishimura S, Yoshino K, Takeuchi T, et al. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjögren's syndrome. J Clin Lab Anal 1993;7:180-7.
25. Bottazzo GF, Pujol BR, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; ii:1115-9.
26. Czarniecki CW, Chiu HH, Wong GH, McCabe SM, Palladino MA. Transforming growth factor-β 1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 1988;140:4217-23.
27. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 1987;166:571-6.
28. Kilshaw PJ, Murant SJ. Expression and regulation of beta 7 (beta p) integrins on mouse lymphocytes: relevance to the mucosal immune system. Eur J Immunol 1991;21:2591-7.
29. Parker CM, Cepek KL, Russell GJ, Shaw SK, Posnett DN, Schwarting R, et al. A family of β7 integrins on human mucosal lymphocytes. Proc Natl Acad Sci USA 1992; 89:1924-8.
30. Chin YH, Cai JP, Xu XM. Transforming growth factor-β 1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes. J Immunol 1992; 148:1106-12.